<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phgenomics</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакогенетика и фармакогеномика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacogenetics and Pharmacogenomics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2588-0527</issn><issn pub-type="epub">2686-8849</issn><publisher><publisher-name>LLC "Izdatelstvo OKI"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2588-0527-2022-2-21-23</article-id><article-id custom-type="elpub" pub-id-type="custom">phgenomics-260</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАРМАКОГЕНЕТИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACOGENETICS STUDY</subject></subj-group></article-categories><title-group><article-title>Полиморфизм CRPC3872T и IgA при разных исходах лечения коинфекции ВИЧ/туберкулёз у госпитализированных пациентов с множественной лекарственной устойчивостью или лекарственной чувствительностью Mycobacterium tuberculosis</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мальцева</surname><given-names>Н. В.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новокузнецк</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Казанцева</surname><given-names>О. М.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новокузнецк</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шрамко</surname><given-names>С. В.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новокузнецк</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Новокузнецкий государственный институт усовершенствования врачей</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>03</day><month>04</month><year>2023</year></pub-date><volume>0</volume><issue>2</issue><fpage>21</fpage><lpage>23</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мальцева Н.В., Казанцева О.М., Шрамко С.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Мальцева Н.В., Казанцева О.М., Шрамко С.В.</copyright-holder><copyright-holder xml:lang="en">Мальцева Н.В., Казанцева О.М., Шрамко С.В.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacogenetics-pharmacogenomics.ru/jour/article/view/260">https://www.pharmacogenetics-pharmacogenomics.ru/jour/article/view/260</self-uri><abstract><p>Цель. Исследовать связь полиморфизма rs1205 CRPC&gt;T (СRPC3872T) и иммуноглобулинов класса А с исходомлечения госпитализированных пациентов с ВИЧ/ТБ и МЛУ МБТ или ЛЧ МБТ.</p></abstract><kwd-group xml:lang="ru"><kwd>полиморфизм генов</kwd><kwd>коинфекция</kwd><kwd>ВИЧ</kwd><kwd>туберкулёз</kwd><kwd>исходы лечения</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zürcher K, Reichmuth ML, Ballif M, et al. Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study. Lancet Microbe. 2021 Jul;2(7):e320–e330. DOI: 10.1016/S2666-5247(21)00044-6.</mixed-citation><mixed-citation xml:lang="en">Zürcher K, Reichmuth ML, Ballif M, et al. Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study. Lancet Microbe. 2021 Jul;2(7):e320–e330. DOI: 10.1016/S2666-5247(21)00044-6.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Li L, Liu Y, Gorny MK. Association of Diverse Genotypes and Phenotypes of Immune Cells and Immunoglobulins With the Course of HIV-1 Infection. Front Immunol. 2018 Nov 26;9:2735. DOI: 10.3389/fimmu.2018.02735.</mixed-citation><mixed-citation xml:lang="en">Li L, Liu Y, Gorny MK. Association of Diverse Genotypes and Phenotypes of Immune Cells and Immunoglobulins With the Course of HIV-1 Infection. Front Immunol. 2018 Nov 26;9:2735. DOI: 10.3389/fimmu.2018.02735.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tran AC, Diogo GR, Paul MJ, et al. Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ. Front Immunol. 2020 Oct 20;11:582833. DOI: 10.3389/fimmu.2020.582833.</mixed-citation><mixed-citation xml:lang="en">Tran AC, Diogo GR, Paul MJ, et al. Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ. Front Immunol. 2020 Oct 20;11:582833. DOI: 10.3389/fimmu.2020.582833.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Santaolalla A, Sollie S, Rislan A, et al. Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study. BMC Immunol. 2021;22:61. DOI: 10.1186/s12865-021-00448-2.</mixed-citation><mixed-citation xml:lang="en">Santaolalla A, Sollie S, Rislan A, et al. Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study. BMC Immunol. 2021;22:61. DOI: 10.1186/s12865-021-00448-2.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
